HIV-1
Clinical trials for HIV-1 explained in plain language.
Never miss a new study
Get alerted when new HIV-1 trials appear
Sign up with your email to follow new studies for HIV-1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lifeline extended: HIV drug access trial keeps treatment flowing for kids and adults
Disease control OngoingThis trial provides continued access to the HIV medication etravirine for children (aged 2+) and adults who successfully completed a previous study with the drug and are still benefiting from it. The goal is to supply the medication until participants can switch to a commercially…
Matched conditions: HIV-1
Phase: PHASE3 • Sponsor: Janssen Sciences Ireland UC • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Early trial tests new shot to boost Body's fight against HIV
Disease control TerminatedThis early-stage study is testing a new therapeutic vaccine in adults who are living with HIV and have their virus well-controlled with daily medication. The main goals are to check if the vaccine is safe and to see if it can teach the body's immune system to better fight the vir…
Matched conditions: HIV-1
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Scientists test antibody duo to shrink HIV's hidden hideouts
Disease control OngoingThis study is testing whether two new antibody drugs, given by IV infusion, are safe and can reduce the amount of hidden, dormant HIV that persists in the body even during effective treatment. It involves 105 adults with well-controlled HIV who are already on standard antiretrovi…
Matched conditions: HIV-1
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC